CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth

RangeMe connects CBDL to over 200,000 retail buyers, including some of the world's largest retailers, driving exponential market opportunities

SCOTTSDALE, AZ / ACCESSWIRE / October 2, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a trailblazer in the booming CBD industry, today announces a strategic leap in expanding its revenue channels by partnering with RangeMe, the premier product discovery and sourcing platform. With access to over 200,000 retail buyers, including key players from leading global retailers, this move sets the stage for monumental growth, further propelling CBDL into the spotlight as a top contender in the CBD market.

As consumer demand for premium CBD products skyrockets, CBDL is uniquely positioned to seize this opportunity. By leveraging RangeMe's vast network, CBDL is unlocking a direct pathway to the largest retail chains in the country, creating untapped revenue potential that could lead to a multi-fold increase in distribution and sales.

"This is just the beginning," said Lisa Nelson, President and CEO of CBD Life Sciences Inc. "We've already achieved an unprecedented 1405.46% revenue growth since February, and by tapping into the power of RangeMe, we're positioning ourselves for explosive results. Our investors have never been more excited, and for good reason-we're on the cusp of something huge."

CBDL's rapid ascent is driven by its innovative product lineup, including its highly sought-after Mellow Mornings CBD Coffee Creamer, a water-soluble, nano CBD-infused product delivering up to 10x more bioavailability than traditional CBD. With more breakthrough products in the pipeline, including a cutting-edge nutritional supplement featuring reishi mushrooms and ashwagandha, CBDL is on track to dominate the wellness space.

The partnership with RangeMe opens the door to a national retail presence, supercharging CBDL's growth trajectory and solidifying its position as a leader in the CBD sector. "We're taking bold steps to not only meet the demands of today's market but to shape the future of wellness," Nelson added. "And the future looks very, very bright."

CBDL's relentless commitment to growth, innovation, and expanding its retail footprint makes it a prime target for investors looking to capitalize on the surging CBD market. With significant milestones achieved and a clear roadmap ahead, the company's future is set for sustained long-term success.

About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC:CBDL) is a forward-thinking, rapidly growing company specializing in the development of innovative, high-quality CBD products designed to enhance health and wellness. From pain relief to stress reduction, CBDL is at the forefront of the CBD revolution, consistently delivering premium products that meet the evolving needs of consumers. With a commitment to cutting-edge science and consumer satisfaction, CBDL is driving growth in the fast-expanding CBD market.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information

Lisa Nelson
CEO
[email protected]
4802091720

Related Images

SOURCE: CBD Life Sciences Inc.

View the original press release on accesswire.com